Type of Posting: Notice of Intent to Revise
Posting Date: 28–Apr–2022
Targeted Official Date: 01–Dec–2023
Expert Committee: Various
In accordance with the 2020–2025 Rules and Procedures of the Council of Experts, this is to provide notice that USP and its Expert Committees, as applicable, intend to revise a Documentary Standard in response to a revision of General Chapter <1724> Semisolid Drug Products—Performance Tests.
General Chapter <1724> was proposed for comment in PF 48(3) and will be official on December 1, 2023. USP has identified another Documentary Standard referencing General Chapter <1724> that will be impacted by the revisions in PF 48(3). General Chapter <1004> will be updated on June 1, 2023 and will become official December 1, 2023.
Interested stakeholders are encouraged to alert USP staff to any impact they may recognize related to the update of those monographs.
Should you have any questions or comments, please contact Margareth R.C. Marques, Senior Principal Scientist (mrm@usp.org), or the affected General Chapter liaison.
CN-23-049-00